Clinical trial
Rapid Renal Sympathetic Denervation for Resistant Hypertension Using the OneShot Renal Denervation System II
NCT01939392 is registered in ClinicalTrials.gov with Medtronic Endovascular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rapid Renal Sympathetic Denervation for Resistant Hypertension Using the OneShot Renal Denervation System II
- Lead sponsor
- Medtronic Endovascular
- Phase
- Phase 2/3
- Overall status
- Withdrawn
- Start date
- September 30, 2013
- Completion date
- September 30, 2018
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
renal artery ablation, resistant hypertension, uncontrolled hypertension